Quantcast

Latest Ketones Stories

2014-06-19 10:12:13

Washington University in St. Louis Researchers have identified the first genetic variations linked to race that begin to explain a higher risk of death among some African American and Caucasian patients taking the anti-clotting drug clopidogrel (Plavix) after a heart attack. These variants increased patients’ risk of dying in the year following a first heart attack, but they appeared to do so for different reasons depending on race, according to a study at Washington University...

Prescription Pain Killer Deaths Outnumber Heroin, Cocaine Overdoses
2014-06-18 07:35:39

Rebekah Eliason for redOrbit.com – Your Universe Online Reports from a new study at McGill University indicate that there are a greater number of deaths from commonly prescribed painkillers than from heroin and cocaine overdose combined. This study is the first of its kind and highlights a huge public health issue. Death from prescribed painkillers has dramatically increased in recent years with 16,000 US deaths in 2010. In per capita opioid consumption, the United States and Canada...

2014-06-16 20:22:21

Supports Government's commitment in the 2013 Speech from the Throne OTTAWA, June 16, 2014 /CNW/ - Today, the Honourable Rona Ambrose, Minister of Health, announced the Government's consultation on a proposal to regulate tamper-resistant properties for prescription drugs that are at a high risk of abuse, including controlled-release oxycodone. The announcement follows the Government's commitment in the 2013 Speech from the Throne to expand its National Anti-Drug Strategy (NADS)...

2014-06-16 08:28:03

Opioidrecovery.ca provides much-needed answers for patients and families about the journey to recovery TORONTO, June 16, 2014 /CNW/ - For the growing number of Canadians living with opioid addiction, deciding to get help is only half the battle. Unfortunately, actually figuring out the journey to recovery and getting treatment can be a long, hard road too. To help empower patients, give them hope and the tools they need to understand addiction and navigate the system, a new online...

2014-06-16 08:27:58

Relmada Therapeutics and Camp Nine Expect Offering Proceeds to Enable It to Achieve Significant Milestones While Advancing It's Drug Development Pipeline NEW YORK, June 16, 2014 /PRNewswire/ -- Camp Nine, Inc. (the "Company"), which conducts its operations through Relmada Therapeutics Inc. ("Relmada") (OTCBB: CMPE), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has completed equity capital raises totaling gross proceeds...

2014-06-12 16:26:24

SAN FRANCISCO, June 12, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca announced that the majority of US Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) members voted that the FDA should not require cardiovascular outcomes trials for the peripherally-acting mu-opioid receptor antagonist (PAMORA) class of drugs, which includes MOVANTIK(TM )(naloxegol oxalate), an investigational...

2014-06-12 12:28:55

LONDON, June 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Moderate Pain - Pipeline Review, H1 2014 http://www.reportbuyer.com/pharma_healthcare/treatments/moderate_pain_pipeline_review_h1_2013.html Moderate Pain - Pipeline Review, H1 2014 Summary Global Markets Direct's, 'Moderate Pain - Pipeline Review, H1 2014', provides an overview of the Moderate Pain's therapeutic pipeline. This report provides comprehensive information on the therapeutic...

2014-06-11 23:00:39

Sunshine Summit Lodge, a Narconon drug rehabilitation program in California, has witnessed the trend of initial drug use change from illicit drugs over to prescription painkillers over the last decade. Because of recent news about the prescription epidemic, the facility is offering solutions through a new series of articles through it’s website, as well as effective treatment. (PRWEB) June 11, 2014 According to the CDC (The Center for Disease Control and Prevention), deaths from...

2014-06-11 12:26:03

President and CEO Mark A. Sirgo Describes BUNAVAIL(TM) Delivery, Competitive Advantages, Market Size and Patient Need RALEIGH, N.C., June 11, 2014 /PRNewswire/ -- Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) was interviewed on Bloomberg TV, TheStreet.com and Business News Network on June 11 regarding BUNAVAIL, BDSI's product for the maintenance treatment of opioid dependence that recently received approval from...

2014-06-11 08:28:27

DATA FROM KINECT 1 AND KINECT 2 TARDIVE DYSKINESIA STUDIES SAN DIEGO, June 11, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that on June 11, 2014, two scientific posters associated with its study of NBI-98854 in Phase IIb clinical trials of tardive dyskinesia patients, will be presented at the 2014 Annual Congress of Parkinson's Disease and Movement Disorders in Stockholm Sweden. This annual meeting brings together over 5,000 clinicians and...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'